Editorial
Published on 12 Feb 2026
Editorial: Mechanisms and therapeutic opportunities of T-cell impairment in cancer immunity and immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2026.1795868
- 496 views
49,917 Publications
volumes
Volume 17 - 2026
Editorial
Published on 12 Feb 2026
Editorial: Exploring sulfur compounds’ role in inflammation and therapeutic potential
Frontiers in Immunology
doi 10.3389/fimmu.2026.1804564
- 277 views
Correction
Published on 12 Feb 2026
Correction: Editorial: Unveiling the next generation of cancer immunity & immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2026.1784505
- 237 views
Original Research
Published on 12 Feb 2026
NCF2 facilitates M2 macrophage polarization in glioblastoma through activation of the notch1–osteopontin axis
Frontiers in Immunology
doi 10.3389/fimmu.2026.1743950
- 450 views
Original Research
Published on 12 Feb 2026
Targeted expression of the immunomodulatory peptide Scy by engineered Escherichia coli Nissle 1917 for alleviating enterotoxigenic E. coli infection
Frontiers in Immunology
doi 10.3389/fimmu.2026.1698243
- 548 views
Original Research
Published on 12 Feb 2026
Tissue-invasive CMV disease is associated with poor prognosis during remission induction therapy for autoimmune inflammatory rheumatic diseases
Frontiers in Immunology
doi 10.3389/fimmu.2026.1696516
- 472 views
Original Research
Published on 12 Feb 2026
Efficacy of Interleukin 8 (IL-8) in the detection of urinary tract infection
Frontiers in Immunology
doi 10.3389/fimmu.2026.1684579
- 385 views
Review
Published on 12 Feb 2026
The emerging role of m6A methylation in prostate-related diseases: mechanisms and clinical implications
Frontiers in Immunology
doi 10.3389/fimmu.2026.1685015
- 258 views
Case Report
Published on 12 Feb 2026
Case Report: Targeted interleukin-6 blockade by siltuximab for cytokine release syndrome control and infection limitation in thirteen patients treated with bi-specific T-cell engagers
Frontiers in Immunology
doi 10.3389/fimmu.2026.1749348
- 376 views
Original Research
Published on 12 Feb 2026
Baseline glucose-to-lymphocyte ratio predicts nivolumab outcomes in advanced non-small cell lung cancer: a multicenter retrospective study
Frontiers in Immunology
doi 10.3389/fimmu.2026.1714533
- 433 views
Original Research
Published on 12 Feb 2026
Identification and validation of prognostic genes related to glycolysis and M2 macrophage in hepatocellular carcinoma: an integrated analysis of bulk RNA sequencing and single-cell RNA sequencing
Frontiers in Immunology
doi 10.3389/fimmu.2026.1710411
- 521 views
Correction
Published on 12 Feb 2026
Correction: Multiplexed longitudinal analysis of the cellular and microbial dynamics of acute polymicrobial sepsis in mice
Frontiers in Immunology
doi 10.3389/fimmu.2026.1794085
- 165 views
Mini Review
Published on 12 Feb 2026
Beyond the Th2 paradigm: CD4+ cytotoxic T lymphocytes as key drivers of tissue damage and fibrosis in IgG4-related disease
Frontiers in Immunology
doi 10.3389/fimmu.2026.1781462
- 353 views
Editorial
Published on 12 Feb 2026
Editorial: Antibody-mediated thrombotic disease
Frontiers in Immunology
doi 10.3389/fimmu.2026.1800389
- 217 views
Original Research
Published on 12 Feb 2026
Cross-talk between lipopolysaccharide tolerance and AGEs in the regulation of macrophage inflammation and cholesterol efflux
Frontiers in Immunology
doi 10.3389/fimmu.2026.1669028
- 302 views
Original Research
Published on 12 Feb 2026
Nocardia rubra cell wall skeleton-induced MARCO expression: implications for improved phagocytosis and cytokine secretion in tumor-associated macrophages
Frontiers in Immunology
doi 10.3389/fimmu.2026.1611476
- 377 views
Original Research
Published on 12 Feb 2026
A composite biomarker based on early dynamic changes in lactate dehydrogenase and PD-L1 expression enhances outcome prediction for immunochemotherapy in HER2-negative advanced gastric cancer
Frontiers in Immunology
doi 10.3389/fimmu.2026.1659007
- 235 views
Original Research
Published on 12 Feb 2026
A Treat-to-Target approach in hereditary angioedema: expert consensus from a European committee
Frontiers in Immunology
doi 10.3389/fimmu.2026.1773279
- 721 views
Original Research
Published on 12 Feb 2026
ALDH1L2 orchestrates redox–growth coupling in renal carcinoma: pan-cancer evidence and mechanistic validation of the ROS–Akt/mTOR/S6K axis
Frontiers in Immunology
doi 10.3389/fimmu.2026.1768010
- 374 views
Case Report
Published on 12 Feb 2026
Prompt clinical and electrophysiological remission of refractory peripheral neuropathy in long-standing rheumatoid arthritis with tocilizumab: a case report
Frontiers in Immunology
doi 10.3389/fimmu.2026.1770170
- 127 views
Systematic Review
Published on 12 Feb 2026
Correlation between PD-L1 expression and clinical pathology, immunobiological markers, and prognosis in gastroenteropancreatic neuroendocrine neoplasms: a systematic review and meta-analysis
Frontiers in Immunology
doi 10.3389/fimmu.2026.1772011
- 268 views
Review
Published on 12 Feb 2026
Targeting cellular source-specific CXCL9 signaling for immunotherapy in oral squamous cell carcinoma
Frontiers in Immunology
doi 10.3389/fimmu.2026.1768606
- 304 views
Original Research
Published on 12 Feb 2026
Association between peripheral IFN-γ+ cytotoxic lymphocytes and response to PD-1/PD-L1-based therapy in hepatocellular carcinoma
Frontiers in Immunology
doi 10.3389/fimmu.2026.1738116
- 279 views